Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Ferrous glycine sulfate

Generic Name: Ferrous glycine sulfate

Drug Type: Small Molecule

Chemical Formula: C_₄H_₁₀FeN_₂O_₈S

CAS Number: 14729-84-1

Unique Ingredient Identifier: 56PS9HY5XI

Overview

No overview information available.

Background

No background information available.

Indication

Used in preventing and treating iron-deficiency anemia.

Associated Conditions

Iron Deficiency (ID)

Clinical Trials

Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients

Phase 4

Recruiting

Posted: 2023/06/12

Sponsor:Alexandria Universit...

ID:NCT05900635

The Effect of Iron Deficiency Anemia During Pregnancy

Phase 4

Completed

Posted: 2015/10/28

Sponsor:Assiut University

ID:NCT02590224

Comparing Intravenous and Oral Iron in Postoperative Anemia

Phase 4

Completed

Posted: 2013/08/01

Sponsor:

Parc de Salut Mar

ID:NCT01913808

A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects

Phase 3

Completed

Posted: 2011/08/30

Sponsor:

Sanol GmbH

ID:NCT01425463

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy